MultivisionDx builds AI-powered decision-support tools for personalized diagnosis and treatment selection for solid cancer.
MultivisionDx has raised €1.0M across 1 funding round from 4 investors, most recently a Pre-Seed round in Dec 2025. Based in Helsinki, Finland; active in AI. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-12-03 | Pre-Seed | €1.0M |
| angel investor,Antler,Helsinki University Funds,Kaikarhenni Oy |
| View deal → |
